PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,277,000 | -3.8% | 1,716,290 | +0.5% | 0.68% | -34.6% |
| Q2 2022 | $1,328,000 | +145.0% | 1,707,509 | +184.9% | 1.05% | +198.9% |
| Q1 2022 | $542,000 | -81.0% | 599,288 | +68.0% | 0.35% | -79.5% |
| Q4 2021 | $2,857,000 | +21.0% | 356,617 | +26.3% | 1.71% | +31.5% |
| Q3 2021 | $2,362,000 | -16.6% | 282,256 | -32.8% | 1.30% | -26.6% |
| Q2 2021 | $2,831,000 | -4.9% | 420,000 | -6.7% | 1.77% | -27.4% |
| Q1 2021 | $2,976,000 | +177.9% | 450,165 | +76.5% | 2.44% | +392.3% |
| Q4 2020 | $1,071,000 | – | 255,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |